Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. / Jensen, Anders A.; Bräuner-Osborne, Hans.

In: Biochemical Pharmacology, Vol. 67, No. 11, 2004, p. 2115-27.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jensen, AA & Bräuner-Osborne, H 2004, 'Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay', Biochemical Pharmacology, vol. 67, no. 11, pp. 2115-27. https://doi.org/10.1016/j.bcp.2004.02.013

APA

Jensen, A. A., & Bräuner-Osborne, H. (2004). Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. Biochemical Pharmacology, 67(11), 2115-27. https://doi.org/10.1016/j.bcp.2004.02.013

Vancouver

Jensen AA, Bräuner-Osborne H. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. Biochemical Pharmacology. 2004;67(11):2115-27. https://doi.org/10.1016/j.bcp.2004.02.013

Author

Jensen, Anders A. ; Bräuner-Osborne, Hans. / Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay. In: Biochemical Pharmacology. 2004 ; Vol. 67, No. 11. pp. 2115-27.

Bibtex

@article{45e847616fc14141844df19b25fd5390,
title = "Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay",
abstract = "We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a conventional [(3) H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay. The K(m) and K(i) values obtained for 12 standard EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the K(i) values obtained in the [(3) H]-d-aspartate assay (r(2) values of 0.92, 0.92, and 0.95, respectively). Furthermore, the pharmacological characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiology studies of the transporters. The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between {"}full{"} and {"}partial{"} substrates at the transporters. Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail. This is the first report of a high throughput screening assay for EAATs. We propose that the assay will be of great use in future studies of the transporters. Although conventional electrophysiology set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amounts of highly reproducible data with relatively little labor. Furthermore, considering that the number of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compound libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacologically novel ligands for the transporters.",
keywords = "Amino Acid Transport System X-AG, Biological Transport, Cells, Cultured, Electrophysiology, Excitatory Amino Acid Transporter 1, Excitatory Amino Acid Transporter 2, Excitatory Amino Acid Transporter 3, Fluorescence, Glutamate Plasma Membrane Transport Proteins, Humans, Membrane Potentials, Symporters, Tritium",
author = "Jensen, {Anders A.} and Hans Br{\"a}uner-Osborne",
year = "2004",
doi = "10.1016/j.bcp.2004.02.013",
language = "English",
volume = "67",
pages = "2115--27",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier",
number = "11",

}

RIS

TY - JOUR

T1 - Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay

AU - Jensen, Anders A.

AU - Bräuner-Osborne, Hans

PY - 2004

Y1 - 2004

N2 - We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a conventional [(3) H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay. The K(m) and K(i) values obtained for 12 standard EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the K(i) values obtained in the [(3) H]-d-aspartate assay (r(2) values of 0.92, 0.92, and 0.95, respectively). Furthermore, the pharmacological characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiology studies of the transporters. The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters. Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail. This is the first report of a high throughput screening assay for EAATs. We propose that the assay will be of great use in future studies of the transporters. Although conventional electrophysiology set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amounts of highly reproducible data with relatively little labor. Furthermore, considering that the number of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compound libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacologically novel ligands for the transporters.

AB - We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a conventional [(3) H]-d-aspartate uptake assay and in a fluorescence-based membrane potential assay, the FLIPR Membrane Potential (FMP) assay. The K(m) and K(i) values obtained for 12 standard EAAT ligands at EAAT1, EAAT2 and EAAT3 in the FMP assay correlated well with the K(i) values obtained in the [(3) H]-d-aspartate assay (r(2) values of 0.92, 0.92, and 0.95, respectively). Furthermore, the pharmacological characteristics of the cell lines in the FMP assay were in good agreement with previous findings in electrophysiology studies of the transporters. The FMP assay was capable of distinguishing between substrates and non-substrate inhibitors and to discriminate between "full" and "partial" substrates at the transporters. Taking advantage of the prolific nature of the FMP assay, interactions of the EAATs with substrates and inhibitors were studied in some detail. This is the first report of a high throughput screening assay for EAATs. We propose that the assay will be of great use in future studies of the transporters. Although conventional electrophysiology set-ups might be superior in terms of studying sophisticated kinetic aspects of the uptake process, the FMP assay enables the collection of considerable amounts of highly reproducible data with relatively little labor. Furthermore, considering that the number of EAAT ligands presently available is limited, and that almost all of these are characterized by low potency and a low degree of subtype selectivity, future screening of compound libraries at the EAAT-cell lines in the FMP assay could help identify structurally and pharmacologically novel ligands for the transporters.

KW - Amino Acid Transport System X-AG

KW - Biological Transport

KW - Cells, Cultured

KW - Electrophysiology

KW - Excitatory Amino Acid Transporter 1

KW - Excitatory Amino Acid Transporter 2

KW - Excitatory Amino Acid Transporter 3

KW - Fluorescence

KW - Glutamate Plasma Membrane Transport Proteins

KW - Humans

KW - Membrane Potentials

KW - Symporters

KW - Tritium

U2 - 10.1016/j.bcp.2004.02.013

DO - 10.1016/j.bcp.2004.02.013

M3 - Journal article

C2 - 15135308

VL - 67

SP - 2115

EP - 2127

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 11

ER -

ID: 38484960